Is Orchid Chemical and Orchid Pharma same?
Orchid Chemicals & Pharmaceuticals announced that the members of the Company at the Annual General Meeting held on 15 September 2015 have approved to change the name of the Company to “Orchid Pharma” and the special resolution was passed with requisite majority.
What happened Orchid Pharma?
It was forced into bankruptcy court in 2017 by Lakshmi Vilas Bank as the company failed to pay back a loan of about 500 million rupees. The Chennai-based pharmaceutical company reported a preliminary net loss for the year ended March 2021, data compiled by Bloomberg show.
Who is the owner of Orchid Pharma?
Kailasam Raghavendra Rao
Kailasam Raghavendra Rao, is an Indian entrepreneur from Chennai and the founder of Orchid Chemicals & Pharmaceuticals Limited, a former top 500 Indian company on D and B listing, in terms of market capitalization.
What is Orchid Pharma?
Established in 1992 as an export-oriented unit (EOU), Orchid Pharma Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing.
Why are pharma orchids increasing?
Orchid Pharma stock: The factor behind the spectacular rise in the share is that new investors bought majority stake in the firm at dirt cheap prices. Share of Orchid Pharma has delivered nearly 10,000% returns to its shareholders in less than five months.
Why Orchid Pharma share price is increasing?
What is API medicine?
Active Pharmaceutical Ingredients i.e., API refers to an active ingredient that is contained in the medication. For instance, the active ingredient for relieving pain is incorporated in the painkiller. It is called API.
Is pharma stocks a good buy?
Pharma companies can be attractive for long-term investors in spite of the volatility. The ever-rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
Who has taken over Orchid Pharma?
JM Financial Institutional Securities Ltd and Edelweiss Securities Ltd will act as brokers for the deal. Dhanuka had taken over the Chennai-based drugmaker in April last year under an insolvency resolution plan. Lenders to Orchid Pharma received Rs 1,116 crore going by the resolution plan offered by Dhanuka.